Friday, 16 October 2026European Markets

SCOR SE Stock Rises 9% So Far On Friday, Outperforms Market

Loading stream...

(vianews) - shares of scor se (cac 40: scr.pa) jumped 9.99% to €25.88 at 14:10 est on friday, following the last session's downward trend. cac 40 is rising 0.7% to €7,433.49, following the last session's upward trend. this seems, up to now, a somewhat up trend trading session today.

scor se's last close was €23.53, 18.1% below its 52-week high of €28.73.

about scor se

scor se, together with its subsidiaries, provides life and non-life reinsurance products in europe, the middle east, africa, the americas, latin america, and asia pacific. it operates in two segments, scor p&c and scor l&h. the scor p&c segment offers reinsurance products in the areas of property, motors, casualty treaties, credit and surety, decennial insurance, aviation, marine and energy, engineering, agricultural risks, and property catastrophes; specialties insurance products, including business solutions, political and credit risks, cyber, and environmental liability; and business ventures and partnerships. the scor l&h segment provides life reinsurance products, such as protection for mortality, morbidity, behavioral risks, disability, long-term care, critical illness, medical, and personal accident. this segment also provides financial solutions that combine traditional life reinsurance with financial components and provide liquidity, balance sheet, solvency, and income improvements to clients; longevity solutions that include products covering the risk of negative deviation from expected results due to the insured or annuitant living longer than assumed in the pricing of insurance covers provided by insurers or pension funds; and distribution solutions. in addition, it is involved in the asset management business. the company was founded in 1970 and is headquartered in paris, france.

earnings per share

as for profitability, scor se has a trailing twelve months eps of €-1.7.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -3.9%.

moving average

scor se's value is way above its 50-day moving average of €22.10 and way above its 200-day moving average of €19.47.

yearly top and bottom value

scor se's stock is valued at €25.88 at 14:10 est, under its 52-week high of €28.73 and way above its 52-week low of €13.31.

more news about scor se (scr.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com